Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer
2013 · Human Gene Therapy Methods · 41 citations
https://doi.org/10.1089/hgtb.2013.022
V
Vania Baldan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
785
Citations
8
h-index
8
i10-index
Vania Baldan is an academic researcher from Autolus (United Kingdom). The author has contributed to research in topics: CAR-T cell therapy research & Virus-based gene therapy research & Immune Cell Function and Interaction. The author has an h-index of 8, co-authored 17 publications.
Papers by this author
worksDual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR
2023 · Molecular Therapy · 31 citations
https://doi.org/10.1016/j.ymthe.2023.03.020
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-024-45854-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat